Skip to main content
SleepCited

Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats.

E F McNiff, L K Cheng, H C Woodfield, H L Fung
Other Research communications in chemical pathology and pharmacology 1978
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D663395'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究タイプ
In Vitro
対象集団
animal model
介入
Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats. None
比較対照
None
主要アウトカム
kidney function
効果の方向
Positive
バイアスリスク
Unclear

Abstract

Urinary and fecal excretion of lead in rats were compared after intravenous administration of L-cysteine and a number of its derivatives. In terms of increasing total lead excretion, L-cysteine ethyl ester was about half as effective as D-penicillamine, whereas L-cysteine and all other derivatives tested were only marginally effective. Interestingly, L-cysteine ethyl ester appeared to increase lead depletion mainly through biliary excretion. This compound may, therefore, have lower renal toxicity than other chelating agents which promote lead excretion principally by increasing urinary elimination. Dietary supplements containing 1% cysteine, 1% ascorbic acid of 1% of both substances did not dramatically increase lead elimination.

Used In Evidence Reviews

Similar Papers